MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.870
-0.010 (-0.53%)
At close: Oct 8, 2025, 4:00 PM EDT
1.890
+0.020 (1.05%)
After-hours: Oct 8, 2025, 6:53 PM EDT
MindWalk Holdings Employees
As of April 30, 2025, MindWalk Holdings had 102 total employees, including 81 full-time and 21 part-time employees. The number of employees increased by 1 or 0.99% compared to the previous year.
Employees
102
Change (1Y)
1
Growth (1Y)
0.99%
Revenue / Employee
$178,574
Profits / Employee
-$206,811
Market Cap
86.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 102 | 1 | 0.99% |
| Apr 30, 2024 | 101 | -1 | -0.98% |
| Apr 30, 2023 | 102 | 17 | 20.00% |
| Apr 30, 2022 | 85 | 12 | 16.44% |
| Apr 30, 2021 | 73 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HYFT News
- 16 days ago - MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - Business Wire
- 23 days ago - MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet - Business Wire
- 5 weeks ago - ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - Business Wire
- 5 weeks ago - ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York - Business Wire
- 6 weeks ago - ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation - Business Wire
- 2 months ago - AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd. - Business Wire
- 2 months ago - ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - Business Wire